Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Post by Pumperknicleon May 29, 2018 8:47am
154 Views
Post# 28092406

Highlights for the First Quarter of 2018

Highlights for the First Quarter of 2018 Highlights for the First Quarter of 2018 
-- Generated $1.3 million in revenue 

-- 2,950 registered patients as at March 31, 2018 

-- Cannabis oil sales represented 29% of Q1 patient revenue 

-- Signed a key supplier agreement to become a medical cannabis supplier to 
Shoppers Drug Mart Inc. 

-- $53.8 million financing increased cash balance to $83.8 million as at 
March 31, 2018 

-- Purchased remaining 50% of GrowWise Health Limited 

-- Progressed on expansion plans to increase annual capacity to 
approximately 17,000kg 

-- Construction progressing on 30,000 square foot Phase 3 expansion at the 
Woodslee Production Facility with GMP extraction facility, laboratory and 
pharmaceutical production facility 
Highlights Subsequent to the First Quarter of 2018 
-- Invested in Fire & Flower Inc. and entered into 3-year preferred supplier 
agreement 

-- Increased patient count 22% to approximately 3,600 patients at May 28, 
2018 since March 31, 2018 

-- Commenced R&D on oral sustained release formulations in collaboration 
with Canntab Therapeutics Limited ("Canntab") 

-- Commenced inventory build for legalization of adult-use recreational 
cannabis in Canada 
First Quarter Financial Summary 
<< Previous
Bullboard Posts
Next >>